1. Cell Cycle/DNA Damage Epigenetics Apoptosis
  2. HDAC Apoptosis
  3. HDAC-IN-92

HDAC-IN-92 是一种泛 HDAC 抑制剂,在 A2780 细胞中的 IC50 为 12.58 µM。HDAC-IN-92 对多种人类癌细胞系表现出广谱且显著的细胞毒活性,涵盖卵巢癌、肝癌及乳腺癌等类型。HDAC-IN-92 可诱导细胞凋亡 (apoptosis),并显著抑制肿瘤细胞集落形成。HDAC-IN-92 可抑制鸡胚绒毛尿囊膜 (CAM) 血管的形成。HDAC-IN-92 在 4T1 肿瘤小鼠模型中表现出抗肿瘤作用。HDAC-IN-92 可用于针对实体瘤的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

HDAC-IN-92

HDAC-IN-92 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

HDAC-IN-92 is a pan-HDAC inhibitor with an IC50 of 12.58 µM in A2780 cells. HDAC-IN-92 demonstrates broad-spectrum, notable cytotoxic activity against a range of human cancer cell lines, including ovarian, liver, and breast carcinomas. HDAC-IN-92 causes apoptosis and demonstrates a notable decrease in tumor cell colony formation. HDAC-IN-92 inhibits the formation of blood vessels in the chick chorioallantoic membrane (CAM). HDAC-IN-92 exhibits anti-tumor effect in a 4T1 tumor-bearing mouse model. HDAC-IN-92 can be used for research targeting solid tumor[1].

体外研究
(In Vitro)

HDAC-IN-92 (compound 6g) (18 小时) 在多种癌细胞系中表现出显著的细胞毒性,IC50 分别为 22.17 μM (MCF-7)、8.46 μM (HepG2)、8.10 μM (A2780)、26.89 μM (A2780cis)、75.90 μM (HT29) 和 14.11 μM (4T1)[1]
HDAC-IN-92 (18 小时) 对癌细胞的细胞毒性与其泛 HDAC 抑制活性之间存在相关性,这表明其抗肿瘤作用可能是通过抑制组蛋白去乙酰化酶所介导的[1]
HDAC-IN-92 (8.10 μM,24 小时) 可显著诱导 A2780 细胞凋亡,使总凋亡细胞比例从1.82 %升至22.17 %,并有效抑制该细胞迁移[1]
HDAC-IN-92 (22.17 μM,10 天) 显著抑制 MCF-7 癌细胞的克隆形成[1]
HDAC-IN-92 (5 μM,96 小时) 在鸡胚绒毛尿囊膜 (CAM) 实验中抑制血管生成的效果与 Vorinostat (HY-10221) 相当,具体表现为分支点、血管数量及总血管长度均显著减少[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Apoptosis Analysis[1]

Cell Line: A2780 cells
Concentration: 8.10 nM
Incubation Time: 24 h
Result: Increased percentage early and late apoptosis cells from 1.82 % of the control to 22.17 %.

Cell Proliferation Assay[1]

Cell Line: MCF-7 cells
Concentration: 22.17 nM
Incubation Time: 24 h
Result: Reduces colony formation in MCF-7 cancer cells.
体内研究
(In Vivo)

HDAC-IN-92 (50 mg/kg,腹腔注射,隔日一次,持续21天) 可抑制 4T1 肿瘤 BALB/c 小鼠模型中的肿瘤生长,且表现出良好的耐受性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Female Balb/c mice (4-6 weeks old) injected subcutaneously with 4T1 cells [1]
Dosage: 50 mg/kg
Administration: i.p., every other day for 21 days
Result: Reduced tumor volume better than Vorinostat.
Exerted no significant effects on the body weight or survival rates of mice.
Induced tumor cell apoptosis without exhibiting toxicity in major organs.
分子量

384.43

Formula

C19H17FN4O2S

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
HDAC-IN-92
目录号:
HY-175857
需求量: